Navigation Links
OrthoAccel Technologies, Inc. Announces New Scientific Advisor
Date:2/23/2011

HOUSTON, Feb. 23, 2011 /PRNewswire/ -- OrthoAccel Technologies, Inc. developers of the AcceleDent System, a medical device to accelerate orthodontic treatment, announced this week that it has engaged Dr. Dawei Liu as a scientific advisor. Dr. Liu's guidance and expertise will help advance the Company's commitment to a research-focused strategy for developing and introducing innovative new products.  

AcceleDent is a simple, removable dental appliance that an orthodontic patient wears in the mouth for 20 minutes daily to accelerate orthodontic tooth movement.  A Phase I clinical trial in 2008 in Houston, Texas demonstrated the safety and clinical utility of the device. The first completed AcceleDent case in private practice was documented last November in the United Kingdom. Dr. Liu's background is particularly relevant to OrthoAccel's focus. His extensive research has centered around the investigation of the effects of mechanical vibration on orthodontic tooth movement, in an attempt to shorten the total treatment time and reduce the risk of root resorption in clinical orthodontic patients.  Previously, he accepted an invitation from Dr. Birte Melsen to work as a Clinical Assistant Professor at the Department of Orthodontics at the Royal Dental College in Denmark.  Currently, he is the pre-doctoral Program Director and Research Director at Marquette University in the Department of Developmental Sciences / Orthodontics.

Michael Lowe, CEO of OrthoAccel, commented, "At OrthoAccel, we are always looking for ways to improve our technologies, and to provide the most scientifically advanced products to our customers.  Dr. Liu's scientific research complements OrthoAccel's objectives.  We believe that he can effectively guide us toward establishing an evidence-based foundation, which is an important objective." Dr. Liu remarked, "AcceleDent has the potential to revolutionize orthodontics and I am looking forward to working with Management to help guide OrthoAccel's future scientific research strategy."

OrthoAccel's Management team is traveling to Europe next month to work on commercialization efforts in several key markets.  

OrthoAccel has completed a pivotal US clinical trial at the UT Health Science Center in San Antonio, and is planning a submission for FDA clearance on AcceleDent later this month.   

About OrthoAccel Technologies, Inc.

Based in Houston, Texas, OrthoAccel Technologies, Inc. is a privately owned medical device company currently engaged in the development, manufacturing, and marketing of products to enhance dental care and orthodontic treatment.  

About the AcceleDent System

AcceleDent represents the first clinical approach to safely accelerate orthodontic tooth movement via modulating biology.  The device has been studied clinically and applies gentle pulsing forces in combination with standard orthodontics to move teeth faster through accelerated bone remodeling.  Importantly, the device works complementary with all existing orthodontic technologies.  AcceleDent is neither FDA cleared nor FDA approved; it is currently investigational only in the United States.  More information can be found at www.acceledent.com or requested via info@orthoaccel.com


'/>"/>
SOURCE OrthoAccel Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Medical Device Industry Executive Joins OrthoAccel Technologies, Inc. Board of Directors
2. OrthoAccel Technologies Committed to Plans for Positioning the United Kingdom as a Key Strategic Market for New Orthodontic Technology
3. OrthoAccel Technologies Announces Full-Market Release of AcceleDent, a New Technology to Shorten Treatment Time in Braces
4. OrthoAccel Technologies, Inc. Announces Definitive Distribution Agreements in Two Key Markets
5. OrthoAccel Technologies, Inc. and AB Orthodontics Announce Partnership and Australian Product Introduction
6. Patient Safety Technologies, Inc. to Present at the ROTH Capital Partners 23rd Annual OC Growth Stock Conference
7. Nopras Technologies, Inc. Achieves ISO 9001:2008 Certification
8. Novo Nordisk A/S and Emisphere Technologies, Inc. Announce License Agreement to Develop Oral Formulation of Insulin for Diabetes
9. China Medical Technologies, Inc. Announces the Closing of US$150 Million Convertible Senior Note Offering and the Completion of Repurchase of US$105.9 Million Convertible Notes Due 2011
10. Reportlinker Adds Proteomics - Technologies, Markets and Companies
11. The Future of GPCRs in Drug Discovery: Novel Technologies, Leading Companies, and Opportunities for Target Expansion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... PUNE, India , June 24, 2016 ... "Pen Needles Market by Type (Standard Pen Needles, Safety ... 12mm), Therapy (Insulin, GLP-1, Growth Hormone), Mode of Purchase ... published by MarketsandMarkets, This report studies the market for ... is expected to reach USD 2.81 Billion by 2021 ...
(Date:6/23/2016)... Research and Markets has announced the addition of the ... report to their offering. ... failure, it replaces the function of kidneys by removing the ... the treatment helps to keep the patient body,s electrolytes such ... Increasing number of ESRD patients & substantial healthcare expenditure on ...
(Date:6/23/2016)... June 23, 2016 Research and Markets ... Medical Market Analysis 2016 - Forecast to 2022" report ... The report contains up to date financial data derived from ... of major trends with potential impact on the market during ... market segmentation which comprises of sub markets, regional and country ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal their media ... Pro X," said Christina Austin - CEO of Pixel Film Studios. , ProSlice ... X users can now reveal the media of their split screens with growing ...
(Date:6/27/2016)... KS (PRWEB) , ... June 27, 2016 , ... TopConsumerReviews.com ... retailers of Eyeglasses . , Millions of individuals in the United States and ... have become a way to both correct vision and make a fashion statement. Even ...
(Date:6/26/2016)... Carolina (PRWEB) , ... June 26, 2016 , ... ... of a new product that was developed to enhance the health of felines. The ... centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, ... Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. ... skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was ...
(Date:6/25/2016)... ... ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors in ... School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green Hospital ... at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train in ...
Breaking Medicine News(10 mins):